226 related articles for article (PubMed ID: 1849177)
21. Papanicolaou test and enzyme-linked in-situ hybridization. A combined diagnostic system for papilloma virus infections with high prognostic value.
Schön HJ; Czerwenka KF; Schurz B; Kramar R; Kubista E
Eur J Clin Chem Clin Biochem; 1991 Feb; 29(2):131-8. PubMed ID: 1646654
[TBL] [Abstract][Full Text] [Related]
22. Significance of atypical cervical cytology in pregnancy.
Kaminski PF; Lyon DS; Sorosky JI; Wheelock JB; Podczaski ES
Am J Perinatol; 1992; 9(5-6):340-3. PubMed ID: 1418129
[TBL] [Abstract][Full Text] [Related]
23. Prediction of cervical intraepithelial neoplasia grade 2-3 using risk assessment and human papillomavirus testing in women with atypia on papanicolaou smears.
Shlay JC; Dunn T; Byers T; Barón AE; Douglas JM
Obstet Gynecol; 2000 Sep; 96(3):410-6. PubMed ID: 10960635
[TBL] [Abstract][Full Text] [Related]
24. [Mild cervix dysplasia: does diagnostic biopsy have a "therapeutic" effect?].
Gitsch G; Kainz C; Reinthaller A; Tatra G; Breitenecker G
Geburtshilfe Frauenheilkd; 1991 Oct; 51(10):806-8. PubMed ID: 1662168
[TBL] [Abstract][Full Text] [Related]
25. Management of the abnormal Papanicolaou smear.
Frisch LE
J Am Coll Health; 1989 May; 37(6):279-82. PubMed ID: 2723260
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis of cervical intraepithelial neoplasia and human papillomavirus infection: punch biopsy versus cervical smear.
Gitsch G; Reinthaller A; Tatra G; Breitenecker G
Arch Gynecol Obstet; 1991; 249(4):179-84. PubMed ID: 1665685
[TBL] [Abstract][Full Text] [Related]
27. A comparison of the human papillomavirus test and Papanicolaou smear as a second screening method for women with minor cytological abnormalities.
Andersson S; Dillner L; Elfgren K; Mints M; Persson M; Rylander E
Acta Obstet Gynecol Scand; 2005 Oct; 84(10):996-1000. PubMed ID: 16167918
[TBL] [Abstract][Full Text] [Related]
28. High rates of atypical cervical cytology: occurrence and clinical significance.
Pearlstone AC; Grigsby PW; Mutch DG
Obstet Gynecol; 1992 Aug; 80(2):191-5. PubMed ID: 1635730
[TBL] [Abstract][Full Text] [Related]
29. Low-grade Papanicolaou smears and the Bethesda system: a prospective cytohistopathologic analysis.
Lonky NM; Navarre GL; Saunders S; Sadeghi M; Wolde-Tsadik G
Obstet Gynecol; 1995 May; 85(5 Pt 1):716-20. PubMed ID: 7724102
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus infection of the cervix detected by cervicovaginal lavage and molecular hybridization: correlation with biopsy results and Papanicolaou smear.
Burk RD; Kadish AS; Calderin S; Romney SL
Am J Obstet Gynecol; 1986 May; 154(5):982-9. PubMed ID: 3010725
[TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus type 31 DNA detected in part of the dysplasia but in no part of the squamous metaplasia in a specimen taken from one patient.
Shimano S; Fukushima M; Nishikawa A; Yamakawa Y; Takashima S; Satoh M; Minase T; Kutuzawa T; Hashimoto M
Jpn J Clin Oncol; 1991 Feb; 21(1):8-12. PubMed ID: 1648636
[TBL] [Abstract][Full Text] [Related]
32. Cytomorphologic correlates of human papillomavirus infection in the "normal" cervicovaginal smear.
Cramer HM; Skinner-Wannemuehler SE; Brown DR; Katz BP; Fife KH
Acta Cytol; 1997; 41(2):261-8. PubMed ID: 9100752
[TBL] [Abstract][Full Text] [Related]
33. [Colposcopic, cytologic and histologic changes in the uterine cervix caused by human papilloma viruses].
Milojković M; Pajtler M; Makarović Z
Lijec Vjesn; 1991; 113(11-12):380-3. PubMed ID: 1669603
[TBL] [Abstract][Full Text] [Related]
34. Presence of human papillomavirus infection of the uterine cervix as determined by different detection methods in a low-risk community-based population.
Zazove P; Reed BD; Gregoire L; Gorenflo DW; Lancaster WD; Ruffin MT; Hruszczyk J
Arch Fam Med; 1993 Dec; 2(12):1250-8. PubMed ID: 8130906
[TBL] [Abstract][Full Text] [Related]
35. ViraPap: can it help to reduce the need for colposcopy?
Mareck DG; Woolard DG
Fam Pract Res J; 1991 Dec; 11(4):405-14. PubMed ID: 1662859
[TBL] [Abstract][Full Text] [Related]
36. Telomerase activity in Papanicolaou smear-negative exfoliated cervical cells and its association with lesions and oncogenic human papillomaviruses.
Zheng PS; Iwasaka T; Zhang ZM; Pater A; Sugimori H
Gynecol Oncol; 2000 Jun; 77(3):394-8. PubMed ID: 10831348
[TBL] [Abstract][Full Text] [Related]
37. Abnormal Papanicolaou smears. Comparison of cytology, colposcopy and cervical swab DNA hybridization.
Powell WS; McKenzie HJ
J Reprod Med; 1992 Jun; 37(6):525-8. PubMed ID: 1320120
[TBL] [Abstract][Full Text] [Related]
38. Detection of human papillomavirus DNA on routine Papanicolaou's smears by in situ hybridization with the use of biotinylated probes.
Choi YJ
Am J Clin Pathol; 1991 Apr; 95(4):475-80. PubMed ID: 1849699
[TBL] [Abstract][Full Text] [Related]
39. Comparison of cytology and cervicography in screening a high risk Australian population for cervical human papillomavirus and cervical intraepithelial neoplasia.
McKinnon KJ; Ford RM; Hunter JC
Aust N Z J Obstet Gynaecol; 1993 May; 33(2):176-9. PubMed ID: 8216120
[TBL] [Abstract][Full Text] [Related]
40. Detection of DNA of human papillomavirus types 6/11 and 16/18 in cell scrapings of the uterine cervix by filter in situ hybridisation. Correlation with cytology, colposcopy and histology.
Demeter T; Kulski JK; Sterrett GF; Pixley EC
Eur J Epidemiol; 1987 Dec; 3(4):404-13. PubMed ID: 2826222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
